Clinical Trials Logo

Clinical Trial Summary

Fibromuscular dysplasia is an non inflammatory non atherosclerotic obstructive arterial disease affecting mid-size arteries. It is considered as a rare vascular disease of unknown origin. Fibromuscular dysplasia may become symptomatic depending on location and severity of narrowing of the arterial lumen. for example,when a stenosis develops within a renal artery, arterial hypertension may develop. The cause of fibromuscular dysplasia is unknown. Several factors have been suggested to be associated with it: tobacco abuse or oestrogens. In order to progress into identifying possible causative mechanisms of the disease, we design a pathophysiology study destined to assess endothelial function in patients with fibromuscular dysplasia and to identify possible plasmatic biomarkers of the disease.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT01935752
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase N/A
Start date November 2011
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT02528149 - Renal Arteries Dysplastic Aneurysms: Anatomopathological and Genetic Study N/A
Recruiting NCT01967511 - Defining the Basis of Fibromuscular Dysplasia (FMD)
Recruiting NCT06065852 - National Registry of Rare Kidney Diseases
Completed NCT02884141 - Cross-sectional Study of Patients With Renal or Craniocervical Fibromuscular Dysplasia N/A
Completed NCT02961868 - Cohort Follow-up of Patients With Renal or Craniocervical Fibromuscular Dysplasia N/A
Recruiting NCT05628948 - Vascular Lab Resource (VLR) Biorepository
Recruiting NCT04804683 - European/International FMD Registry and Initiative N/A
Recruiting NCT03596437 - Study of Arterial Properties by Ultra-high Frequency Ultrasound in Fibromuscular Dysplasia and Vascular Ehlers-Danlos Syndrome N/A
Completed NCT01808729 - CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium N/A
Recruiting NCT04906356 - Canadian SCAD Study
Recruiting NCT05491980 - Florida Cerebrovascular Disease Biorepository and Genomics Center